The global non-opioid pain patches market size is expected to
reach USD 1.04 billion by 2026, expanding at a CAGR of 4.6% during the forecast
period, according to a new report by Grand View Research, Inc. Some of the key
factors driving the market are rising incidence of pain related disorders and
the various benefits offered by these patches over other forms of medication
used to alleviate acute and chronic pain.
According to the AAPM, chronic pain affects more
individuals than cancer, diabetes, and coronary heart disease combined in the
U.S. Estimates from the American Chiropractic Association indicate that
American citizens spend at least USD 50 billion every year on back-related
ailments. These facts are indicative of the growing need for therapies to
alleviate pain globally.
Opioid medications are usually sought for the
treatment of pain and related disorders despite resulting in dependence and
abuse in majority of patients. The rising addiction to opioid drugs has
encouraged many countries to develop alternate therapies to alleviate
discomfort. In November 2017, opioid epidemic in the U.S. was declared as a
national emergency. Thus, demand for safe and effective therapies that ease the
underlying discomfort with reduced adverse effects are sought by governments,
thus accelerating the market growth.
According to a new study published by Substance
Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults
in America were prescribed painkillers by medical providers. Statistics from
the same source also indicate that these medications were used more than
cigarettes, cigars, and smokeless tobacco combined. Most of these oral
medicines fall under the opiate category are usually more prone to be addictive
and used in combination with other consumables such as alcohol and other drugs.
Growing awareness about the adverse effects associated with these drugs has led
to the development of alternatives such as non-opioid pain patches to deliver
the same therapeutic effect and aid in pain management.
Browse full research report on Non-opioid
Pain Patches Market: https://www.grandviewresearch.com/industry-analysis/non-opioid-pain-patches-market
Further Key
Findings From the Study Suggest:
- Methyl salicylate
patches are expected to gain significant revenue during the forecast
period owing to increase in product penetration and consumer adoption
- North America held
the largest revenue share due to local presence of major non-opioid pain
patch market players and increasing R&D in the field of pain
management to cater to a rising number of patients
- The Asia Pacific
region is expected to account for the highest CAGR during the forecast
period owing to rise in investments by dominant players in the region and
developments in the pharmaceutical industry in emerging countries such as
India and China
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/non-opioid-pain-patches-market/request/rs1
Grand
View Research has segmented the global non-opioid pain patches market report on
the basis of patch type, distribution channel, and region:
Non-opioid Pain
Patch Type (Revenue, USD Million; 2015 - 2026)
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate
Patches
- Capsaicin Patches
- Ketoprofen Patches
Non-opioid Pain
Patch Distribution Channel Outlook (Revenue, USD Million; 2015 - 2026)
- Hospitals
- Online Pharmacies
- Drug Stores
Non-opioid Pain
Patch Regional Outlook (Revenue, USD Million; 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment